AR024686A1 - Un metodo para sintetizar un peptido - Google Patents
Un metodo para sintetizar un peptidoInfo
- Publication number
- AR024686A1 AR024686A1 ARP000103508A ARP000103508A AR024686A1 AR 024686 A1 AR024686 A1 AR 024686A1 AR P000103508 A ARP000103508 A AR P000103508A AR P000103508 A ARP000103508 A AR P000103508A AR 024686 A1 AR024686 A1 AR 024686A1
- Authority
- AR
- Argentina
- Prior art keywords
- peptide
- peptides
- seq
- group
- protected side
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 5
- 230000002194 synthesizing effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108010033276 Peptide Fragments Proteins 0.000 abstract 2
- 102000007079 Peptide Fragments Human genes 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 108010037251 peptide T1249 Proteins 0.000 abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 238000010647 peptide synthesis reaction Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se revelan métodos para la síntesis de péptidos, a los que en la presente se hace referencia como péptidos T-1249 (SEQ ID NO:1) y péptidos similares a losT-1249. Dichos métodos recurren al empleo de procedimientos de síntesis en fase líquida ysolida a fin de sintetizar y combinar grupos de fragmentos depéptidos específicos a fin de proporcionar el péptido que resulta de interés. La presente se refiere, del mismo modo, a fragmentos de péptidos individuales queactuan como productosintermedios en la síntesis de los péptidos que resultan de interés (por ejemplo el T-1249). También, la presente se refiere a grupos dedichos fragmentos de productos intermedios de péptidos que se pueden utilizar en conjunto para producir péptidos T- 1249 y similar es al T-1249 de longitudcompleta. Particularmente se revela un método para preparar péptidos de la formula: X-WQEWEQKITALLEQAQIQQEKNEYELQKLDKWASLWEWF-Z (SEQ ID NO:1) caracterizadoporque comprende: (a) efectuar la reaccion de unpéptido de cadena late ral protegida de la siguiente formula: EQAQIQQEKNEYELQKLDKWASLWEWF-Z (SEQ ID NO:6), enla cual el término amino se encuentra desprotegido; con un péptido de cadena lateral protegida de la formula: X-WQEWEQKITALL-COOH (SEQ IDNO:2), paraproporcionar un péptido de cadena lateral protegida de la siguiente formula: X-WQEWEQKITALLEQAQIQQEKNEYELQKLDKWASLWEWF-Z (SEQ ID NO: 1); en la cual X es ungrupo protector, un grupo acetilo o un grupo portador macromolecular, y en la cualZ es un grupo protector, un grupo amido o un grupo portador macromolecular.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/349,205 US6469136B1 (en) | 1999-07-07 | 1999-07-07 | Methods and composition for peptide synthesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR024686A1 true AR024686A1 (es) | 2002-10-23 |
Family
ID=23371340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000103508A AR024686A1 (es) | 1999-07-07 | 2000-07-07 | Un metodo para sintetizar un peptido |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6469136B1 (es) |
| EP (1) | EP1372686B1 (es) |
| JP (1) | JP2003530311A (es) |
| KR (1) | KR100631874B1 (es) |
| CN (1) | CN1267449C (es) |
| AR (1) | AR024686A1 (es) |
| AT (1) | ATE288278T1 (es) |
| AU (1) | AU4133701A (es) |
| BR (1) | BR0012249A (es) |
| CA (1) | CA2378086A1 (es) |
| DE (1) | DE60017955T2 (es) |
| DK (1) | DK1372686T3 (es) |
| ES (1) | ES2236043T3 (es) |
| MX (1) | MXPA02000021A (es) |
| PT (1) | PT1372686E (es) |
| TW (1) | TWI237640B (es) |
| WO (1) | WO2001034635A2 (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6656906B1 (en) * | 1998-05-20 | 2003-12-02 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| SK782002A3 (en) * | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| JP4381302B2 (ja) * | 2002-07-24 | 2009-12-09 | エフ．ホフマン−ラ ロシュ アーゲー | Ｐｅｇ化ｔ１２４９ポリペプチド |
| US20040158037A1 (en) * | 2003-02-12 | 2004-08-12 | Bohling James Charles | Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and biologically active substances and therapeutics produced therewith |
| AU2004200485A1 (en) * | 2003-02-25 | 2004-09-09 | Rohm And Haas Company | Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| EP3552627A1 (en) * | 2003-05-06 | 2019-10-16 | Bioverativ Therapeutics Inc. | Clotting factor-fc chimeric proteins to treat hemophilia |
| US7348004B2 (en) | 2003-05-06 | 2008-03-25 | Syntonix Pharmaceuticals, Inc. | Immunoglobulin chimeric monomer-dimer hybrids |
| EP1701971A2 (en) * | 2003-12-31 | 2006-09-20 | F.Hoffmann-La Roche Ag | Peptide synthesis using decanting filter |
| ES2295961T3 (es) * | 2003-12-31 | 2008-04-16 | F. Hoffmann-La Roche Ag | Proceso para la sintesis peptidica utilizacndo una cantidad reducida de agente de desproteccion. |
| WO2005063799A2 (en) * | 2003-12-31 | 2005-07-14 | F.Hoffmann-La Roche Ag | Peptide synthesis and deprotection with co-solvent |
| EP1701972B1 (en) * | 2003-12-31 | 2008-10-08 | F. Hoffmann-La Roche Ag | Process and systems for recovery of peptides |
| EP1701970A2 (en) * | 2003-12-31 | 2006-09-20 | F.Hoffmann-La Roche Ag | Methods for recovering cleaved peptide from a support |
| EP1725262B1 (en) * | 2004-03-15 | 2021-05-26 | Nektar Therapeutics | Polymer-based compositions and conjugates of hiv entry inhibitors |
| WO2006069779A1 (en) * | 2004-12-30 | 2006-07-06 | F. Hoffmann-La Roche Ag | Preparing of peptides with excellent solubility |
| ATE439371T1 (de) * | 2004-12-30 | 2009-08-15 | Hoffmann La Roche | Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten |
| ES2332418T3 (es) * | 2004-12-30 | 2010-02-04 | F. Hoffmann-La Roche Ag | Sintesis del peptido t-20 empleando fragmentos intermedios del peptido. |
| WO2006069697A1 (en) * | 2004-12-30 | 2006-07-06 | F. Hoffmann-La Roche Ag | Colorimetrically assessing peptide characteristics |
| WO2006105199A2 (en) * | 2005-03-30 | 2006-10-05 | Trimeris, Inc. | Compositions and methods for synthesis of peptide and related conjugate |
| TW200745163A (en) * | 2006-02-17 | 2007-12-16 | Syntonix Pharmaceuticals Inc | Peptides that block the binding of IgG to FcRn |
| CA2651070A1 (en) | 2006-05-03 | 2007-11-15 | Mallinckrodt Inc. | Composition and method for the release of protected peptides from a resin |
| CN101195653B (zh) * | 2006-12-08 | 2010-05-12 | 吉尔生化（上海）有限公司 | 亮丙瑞林的固液合成法 |
| US8906844B2 (en) * | 2007-08-09 | 2014-12-09 | Biogen Idec Hemophilia Inc. | Immunomodulatory peptides |
| CA2700354A1 (en) * | 2007-09-25 | 2009-04-02 | Trimeris, Inc. | Novel methods of synthesis for therapeutic antiviral peptides |
| JP5473925B2 (ja) * | 2007-10-27 | 2014-04-16 | コーデン ファーマ コロラド インコーポレイテッド | 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成 |
| JP2011506376A (ja) * | 2007-12-11 | 2011-03-03 | エフ．ホフマン−ラ ロシュ アーゲー | 固相及び溶液相の組み合わせ技術を使用したインシュリン分泌性ペプチド合成 |
| US20100048488A1 (en) * | 2008-08-01 | 2010-02-25 | Syntonix Pharmaceuticals, Inc. | Immunomodulatory peptides |
| AU2011274423B2 (en) | 2010-07-09 | 2016-02-11 | Bioverativ Therapeutics Inc. | Chimeric clotting factors |
| CN102268065A (zh) * | 2011-06-23 | 2011-12-07 | 成都圣诺科技发展有限公司 | 氨基保护丝氨酸寡肽及其制备方法和用途 |
| CN102603869B (zh) * | 2012-03-27 | 2013-03-27 | 西安华澳丽康生物工程有限公司 | 六胜肽的合成方法 |
| JP6387392B2 (ja) | 2013-03-15 | 2018-09-05 | バイオベラティブ セラピューティクス インコーポレイテッド | 第ｉｘ因子ポリペプチド製剤 |
| HK1219477A1 (zh) | 2013-03-21 | 2017-04-07 | Sanofi-Aventis Deutschland Gmbh | 合成含有乙内酰脲的肽产物 |
| EP2976325B1 (en) | 2013-03-21 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Synthesis of cyclic imide containing peptide products |
| CN108572171A (zh) * | 2017-03-10 | 2018-09-25 | 江苏金斯瑞生物科技有限公司 | 一种检测哌啶残留的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69326069T2 (de) | 1992-07-20 | 2000-03-23 | Duke University, Durham | Zusammensetzungen die die hiv replikation inhibieren |
| CA2150371C (en) | 1992-12-11 | 2002-09-17 | Dov Borovsky | Materials and methods for control of pests |
| EP0708659A4 (en) | 1993-06-07 | 2000-08-23 | Genentech Inc | HIV ENVELOPE POLYPEPTIDES |
| US5464933A (en) | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
| US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
| BR9909018A (pt) * | 1998-03-23 | 2001-10-16 | Trimeris Inc | Processo para a sìntese de um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo |
| US6258782B1 (en) * | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| US6217666B1 (en) | 1998-08-31 | 2001-04-17 | Danieli Technology, Inc. | Countercurrent reduction of oxides on moving metal |
-
1999
- 1999-07-07 US US09/349,205 patent/US6469136B1/en not_active Expired - Fee Related
-
2000
- 2000-07-05 DE DE60017955T patent/DE60017955T2/de not_active Expired - Fee Related
- 2000-07-05 CN CNB008125309A patent/CN1267449C/zh not_active Expired - Fee Related
- 2000-07-05 JP JP2001537346A patent/JP2003530311A/ja not_active Ceased
- 2000-07-05 DK DK00992116T patent/DK1372686T3/da active
- 2000-07-05 PT PT00992116T patent/PT1372686E/pt unknown
- 2000-07-05 ES ES00992116T patent/ES2236043T3/es not_active Expired - Lifetime
- 2000-07-05 WO PCT/US2000/035725 patent/WO2001034635A2/en not_active Ceased
- 2000-07-05 MX MXPA02000021A patent/MXPA02000021A/es active IP Right Grant
- 2000-07-05 KR KR1020027000199A patent/KR100631874B1/ko not_active Expired - Fee Related
- 2000-07-05 BR BR0012249-1A patent/BR0012249A/pt not_active IP Right Cessation
- 2000-07-05 EP EP00992116A patent/EP1372686B1/en not_active Expired - Lifetime
- 2000-07-05 CA CA002378086A patent/CA2378086A1/en not_active Abandoned
- 2000-07-05 AT AT00992116T patent/ATE288278T1/de not_active IP Right Cessation
- 2000-07-05 AU AU41337/01A patent/AU4133701A/en not_active Abandoned
- 2000-07-07 AR ARP000103508A patent/AR024686A1/es active IP Right Grant
- 2000-08-05 TW TW089113543A patent/TWI237640B/zh active
-
2002
- 2002-03-29 US US10/109,748 patent/US6767993B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1372686A4 (en) | 2004-01-02 |
| TWI237640B (en) | 2005-08-11 |
| MXPA02000021A (es) | 2002-07-02 |
| CN1450906A (zh) | 2003-10-22 |
| BR0012249A (pt) | 2003-11-11 |
| EP1372686B1 (en) | 2005-02-02 |
| KR100631874B1 (ko) | 2006-10-09 |
| ES2236043T3 (es) | 2005-07-16 |
| WO2001034635A2 (en) | 2001-05-17 |
| WO2001034635A3 (en) | 2003-10-16 |
| PT1372686E (pt) | 2005-05-31 |
| AU4133701A (en) | 2001-06-06 |
| ATE288278T1 (de) | 2005-02-15 |
| DE60017955D1 (de) | 2005-03-10 |
| DE60017955T2 (de) | 2006-01-12 |
| KR20020038676A (ko) | 2002-05-23 |
| WO2001034635A9 (en) | 2002-08-01 |
| JP2003530311A (ja) | 2003-10-14 |
| US20030125516A1 (en) | 2003-07-03 |
| CA2378086A1 (en) | 2001-05-17 |
| EP1372686A2 (en) | 2004-01-02 |
| US6767993B2 (en) | 2004-07-27 |
| CN1267449C (zh) | 2006-08-02 |
| US6469136B1 (en) | 2002-10-22 |
| DK1372686T3 (da) | 2005-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR024686A1 (es) | Un metodo para sintetizar un peptido | |
| BRPI9909018B8 (pt) | processo para a síntese de um peptídeo | |
| BR9909018A (pt) | Processo para a sìntese de um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo | |
| BR0314071A (pt) | Derivados de pró-droga de 1,3-diamino-2-hidroxipropano | |
| UA110599C2 (uk) | Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку | |
| DK2027152T3 (da) | Peptidfragmenter til induktion af syntese af ekstracellulære matrixproteiner | |
| CY1113850T1 (el) | Νεα παραγωγα ινσουλινης | |
| BR9910296A (pt) | Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado | |
| BR0112540A (pt) | Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c | |
| UA103882C2 (uk) | Композиція пухлино-асоційованих пептидів та відповідна протиракова вакцина | |
| BRPI0515649A (pt) | processo para preparação de composições de anticorpos altamente concentradas e processo para concentrar proteìnas | |
| BR0309712A (pt) | Processo para a preparação de carbonitrilas 7-substituìda-3-quinolina e 3-quinol-4-ona | |
| BR9807349A (pt) | Composto, processos para preparar um composto e para preparar 6-o-alquil eritromicina a. | |
| MXPA06000854A (es) | Polipeptidos para inducir una respuesta inmune protectora en contra de staphylococcus aureus. | |
| AR074944A1 (es) | Proceso para la produccion de bivalirudina | |
| BRPI0417992A (pt) | método para purificar fsh | |
| BR0301667A (pt) | Processo para a preparação de polìmeros em emulsão com pureza elevada | |
| BR9407693A (pt) | Sequência nucleotídica vetor composiçao farmacêutica utilizaçao do vetor e de um composto | |
| BRPI0416916A (pt) | promotores para expressão em vìrus de vacìnia modificada ankara | |
| FI956055A0 (fi) | Tekijä VII:sta johdettuja peptidejä | |
| BRPI0309195B8 (pt) | derivados organossilicone de amino hidroxibenzofenonas, polímero de diorganossiloxano linear, processo para preparação dos referidos derivados, composição cosmética e uso dos referidos derivados como filtros de uv-a em preparações comésticas | |
| BR0209842A (pt) | Processo para a preparação de imipenem | |
| YU18399A (sh) | Postupak alkilacije zaštićenih sulfonamida | |
| BR9606624A (pt) | Processo para a cristalização de (s)-n,n'-bisÚ2-hidróxi-1-(hidroximetil)etil¾-5-Ú(2-hidróxi-1-oxopropil)amino¾-2,4,6-triiodo-1,3-benzonodicar-boxamida a partir de água | |
| BR0107655A (pt) | Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |